Aussie Flu Vaccine Urged For Blacklisting By U.S. Panel
This article was originally published in PharmAsia News
Executive Summary
Australia-made flu vaccines have been recommended for blacklisting by a U.S. panel, citing problems encountered with the drug in Australia and New Zealand